Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: A six months post-treatment follow-up study

QR Code

Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: A six months post-treatment follow-up study

Background: In a recent trial of artemisinin-naphthoquine (artemisinin-NQ) and artemether-lumefantrine (AM-LM) therapy in young children from Papua New Guinea (PNG), there were no treatment failures in artemisinin-NQ-treated children with Plasmodium falciparum or Plasmodium vivax compared with 2.2%...

Full description

Bibliographic Details
Main Authors:	Laman, M., Benjamin, J., Moore, Brioni, Salib, M., Tawat, S., Davis, W., Siba, P., Robinson, L., Davis, T.
Format:	Journal Article
Published:	BioMed Central 2015
Online Access:	http://hdl.handle.net/20.500.11937/33377

Similar Items

Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
by: Moore, Brioni, et al.
Published: (2017)

Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial
by: Laman, M., et al.
Published: (2014)

Population Pharmacokinetics of Artemether, Lumefantrine, and Their Respective Metabolites in Papua New Guinean Children with Uncomplicated Malaria
by: Salman, S., et al.
Published: (2011)

Artemisinin-Naphthoquine Combination Therapy for Uncomplicated Pediatric Malaria: a Pharmacokinetic Study
by: Batty, Kevin, et al.
Published: (2012)

Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria
by: Karl, S., et al.
Published: (2016)

Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: A tolerability, safety, and preliminary efficacy study
by: Benjamin, J., et al.
Published: (2012)

Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria
by: Salman, S., et al.
Published: (2012)

Comparison of an assumed versus measured leucocyte count in parasite density calculations in Papua New Guinean children with uncomplicated malaria
by: Laman, M., et al.
Published: (2014)

Meningeal inflammation increases cerebrospinal fluid artemether concentrations in Papua New Guinean children treated with intramuscular artemether
by: Manning, L., et al.
Published: (2011)

Effect of coadministered fat on the tolerability, safety and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria
by: Moore, Brioni, et al.
Published: (2014)

Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy
by: Moore, Brioni, et al.
Published: (2016)

Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review
by: Egunsola, Oluwaseun, et al.
Published: (2013)

Gametocyte clearance kinetics determined by quantitative magnetic fractionation in Melanesian children with uncomplicated malaria treated with artemisinin combination therapy
by: Karl, S., et al.
Published: (2015)

The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children
by: Sugiarto, S.R., et al.
Published: (2022)

Artemisinin therapy for malaria in hemoglobinopathies: A systematic review
by: Sugiarto, S., et al.
Published: (2018)

Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: Feasibility of abbreviated high-dose regimens for radical cure of vivax malaria
by: Moore, Brioni, et al.
Published: (2014)

PHARMACOKINETICS OF TRANSFER OF PIPERAQUINE INTO THE BREAST MILK OF PAPUA NEW GUINEAN MOTHERS
by: Moore, B., et al.
Published: (2015)

Liver injury in uncomplicated malaria: an overlooked phenomenon.
by: Moore, Brioni
Published: (2018)

Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women
by: Benjamin, J., et al.
Published: (2015)

Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria
by: Karl, S., et al.
Published: (2014)

Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections
by: Mukap, M., et al.
Published: (2018)

Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women
by: Moore, B., et al.
Published: (2016)

Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria
by: Karunajeewa, H., et al.
Published: (2008)

Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model
by: Patel, K., et al.
Published: (2014)

Microbial transformations of artemisinin – anti-malaria drug
by: Omar, Muhammad Nor, et al.
Published: (2012)

The timing of action of artemisinin on the malaria parasite, plasmodium falciparum
by: Desa, Nurul Wahida Md
Published: (2016)

Treatment regimens for pregnant women with falciparum malaria
by: Moore, Brioni, et al.
Published: (2016)

Pharmacotherapy for the prevention of malaria in pregnant women: currently available drugs and challenges
by: Moore, Brioni, et al.
Published: (2018)

Biotechnological transformation of artemisinin: toward an effective antim-malaria drug
by: Omar, Muhammad Nor, et al.
Published: (2012)

Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial
by: Pomat, William, et al.
Published: (2013)

Anti-inflammatory and antibacterial effects of kinos from Australian and Papua New Guinean Eucalyptus species
by: Mungkaje, Martha Yahimbu
Published: (2015)

Emerging possibilities and constraints to Papua New Guinean smallholder coffee producers entering the speciality coffee market
by: Murray-Prior, Roy, et al.
Published: (2007)

Maternal Antibodies to Pneumolysin but Not to Pneumococcal Surface Protein A Delay Early Pneumococcal Carriage in High-Risk Papua New Guinean Infants
by: Francis, Jacinta, et al.
Published: (2009)

An evaluation of patients’ adherence with hypoglycemic medications among Papua New Guineans with Type 2 Diabetes: Influencing factors
by: Pihau-Tulo, Stella, et al.
Published: (2014)

Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea
by: Koleala, T., et al.
Published: (2015)

Penyaringan metabolisme hati dan kajian mekanisme agen anti-malaria artemisinin dan dihidroartemisinin
by: Hussin, Abas Hj, et al.
Published: (1999)

Development of a Papua New Guinean onshore carbonate reservoir: A comparative borehole image (FMI) and petrographic evaluation
by: Wilson, Moyra, et al.
Published: (2013)

The impact of an intervention program for the treatment of malaria in children in Papua New Guinea
by: Joshua, Isaac B.
Published: (2003)

Artemisinin and its derivatives
by: Ilett, Kenneth, et al.
Published: (2005)

The acute phase response in children with mild and severe malaria in Papua New Guinea
by: O'Donnell, A., et al.
Published: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6ifi5i66214co8d0vbetkjccec